Screening for cell migration inhibitors via automated microscopy reveals a rho-kinase inhibitor

被引:108
|
作者
Yarrow, JC [1 ]
Totsukawa, G
Charras, GT
Mitchison, TJ
机构
[1] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA
[3] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA
来源
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 03期
关键词
D O I
10.1016/j.chembiol.2005.01.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small-molecule kinase inhibitors are predominantly discovered in pure protein assays. We have discovered an inhibitor of Rho-kinase (ROCK) through an image-based, high-throughput screen of cell monolayer wound healing. Using automated microscopy, we screened a library of 16,000 compounds finding many that affected cell migration or cell morphology as well as compounds that blocked mitotic progression. We tested 200 compounds in a series of subassays and chose one, 3-(4-pyridyl)indole (Rockout), for more detailed characterization. Rockout inhibits blebbing and causes dissolution of actin stress fibers, phenocopying Rho-kinase inhibitors. Testing Rho-kinase activity in vitro, Rockout inhibits with an IC50 of 25 mu M (5-fold less potent than Y-27632) but has a similar specificity profile. We also profile the wound healing assay with a library of compounds with known bioactivities, revealing multiple pathways involved in the biology.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 50 条
  • [31] Rho-kinase inhibitors: Role in corneal endothelial disorders
    Singh, Nimish Kumar
    Sahu, Srikant Kumar
    SEMINARS IN OPHTHALMOLOGY, 2023, 38 (01) : 9 - 14
  • [32] Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases
    Hirooka Y.
    Shimokawa H.
    American Journal of Cardiovascular Drugs, 2005, 5 (1) : 31 - 39
  • [33] Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
    Jun Wang
    Hanke Wang
    Yalong Dang
    Ophthalmology and Therapy, 2023, 12 (6) : 2943 - 2957
  • [34] Identification of novel substrates for Rho-kinase by proteomic screening
    Tsumura, Yuuta
    Taki, Kentaro
    Harada, Hidenori
    Amano, Mutsuki
    Kaibuchi, Kozo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 290P - 290P
  • [35] Migration of human tubular epithelial cells on different extracellular matrices: Modulation by Rho-kinase inhibitors
    Kroening, S.
    Keller, C.
    Goppelt-Struebe, M.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 : 17 - 18
  • [36] Rho/Rho-kinase: a role in spontaneous tumor cell locomotion
    Wicki, A
    Niggli, V
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 261A - 261A
  • [37] Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity
    Bonn, Stefan
    Herrero, Saturnino
    Breitenlechner, Christine B.
    Erlbruch, Andrea
    Lehmann, Wolf
    Engh, Richard A.
    Gassel, Michael
    Bossemeyer, Dirk
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (34) : 24818 - 24830
  • [38] Rho-kinase and myosin II activities are required for cell type and environment specific migration
    Nakayama, M
    Amano, M
    Katsumi, A
    Kaneko, T
    Kawabata, S
    Takefuji, M
    Kaibuchi, K
    GENES TO CELLS, 2005, 10 (02) : 107 - 117
  • [39] Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors
    Guan, Ronggui
    Xu, Xiaoyu
    Chen, Meihui
    Hu, Haiyan
    Ge, Hu
    Wen, Shijun
    Zhou, Shiyou
    Pi, Rongbiao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 613 - 622
  • [40] Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo
    Deng, Lin
    Li, Gang
    Li, Ronghui
    Liu, Qinglin
    He, Qiaowei
    Zhang, Jian
    CANCER BIOLOGY & THERAPY, 2010, 9 (11) : 875 - 884